SLAM (protéine)

Les SLAM (pour « Signaling lymphocytic activation molecule ») constituent une famille de protéines.

Les différents membres en sont :

SLAMF1 (CD150)
SLAMF2 (CD48)^[1]
SLAMF3 (CD229, LY9)
SLAMF4 (CD244)
SLAMF5 (CD84)
SLAMF6 (CD352)^[2]
SLAMF7 (CD319)^[3]
SLAMF8 (CD353)^[4]
SLAMF9^[5]

Notes et références[modifier | modifier le code]

↑ J Sintes et P Engel, « SLAM (CD150) is a multitasking immunoreceptor: From cosignalling to bacterial recognition », Immunology and cell biology, vol. 89, n^o 2,‎ 2011, p. 161–3 (PMID 21102539, DOI 10.1038/icb.2010.145)
↑ M. Chatterjee, K. Kis-Toth, T. H. Thai, C. Terhorst et G. C. Tsokos, « SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells. », Autoimmunity, vol. 44, n^o 3,‎ mai 2011, p. 211–8 (PMID 21231893, DOI 10.3109/08916934.2010.530627)
↑ JR Kim, NC Horton, SO Mathew et PA Mathew, « CS1 (SLAMF7) inhibits production of proinflammatory cytokines by activated monocytes », Inflammation research : official journal of the European Histamine Research Society ... et al., vol. 62, n^o 8,‎ 2013, p. 765–72 (PMID 23695528, DOI 10.1007/s00011-013-0632-1)
↑ G Wang, AC Abadía-Molina, SB Berger, X Romero, MS O'Keeffe, DI Rojas-Barros, M Aleman, G Liao, E Maganto-García, M. Fresno, N. Wang, C. Detre et C. Terhorst, « Cutting edge: Slamf8 is a negative regulator of Nox2 activity in macrophages », Journal of immunology (Baltimore, Md. : 1950), vol. 188, n^o 12,‎ 2012, p. 5829–32 (PMID 22593622, PMCID 3370125, DOI 10.4049/jimmunol.1102620)
↑ (en) Sebastian Pott, Nima K. Kamrani, Guillaume Bourque, Sven Pettersson et Edison T. Liu, « PPARG Binding Landscapes in Macrophages Suggest a Genome-Wide Contribution of PU.1 to Divergent PPARG Binding in Human and Mouse », PLoS ONE, vol. 7, n^o 10,‎ 2012, e48102 (DOI 10.1371/journal.pone.0048102)

Portail de la biologie cellulaire et moléculaire

[1] J Sintes et P Engel, « SLAM (CD150) is a multitasking immunoreceptor: From cosignalling to bacterial recognition », Immunology and cell biology, vol. 89, n^o 2,‎ 2011, p. 161–3 (PMID 21102539, DOI 10.1038/icb.2010.145)

[2] M. Chatterjee, K. Kis-Toth, T. H. Thai, C. Terhorst et G. C. Tsokos, « SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells. », Autoimmunity, vol. 44, n^o 3,‎ mai 2011, p. 211–8 (PMID 21231893, DOI 10.3109/08916934.2010.530627)

[3] JR Kim, NC Horton, SO Mathew et PA Mathew, « CS1 (SLAMF7) inhibits production of proinflammatory cytokines by activated monocytes », Inflammation research : official journal of the European Histamine Research Society ... et al., vol. 62, n^o 8,‎ 2013, p. 765–72 (PMID 23695528, DOI 10.1007/s00011-013-0632-1)

[4] G Wang, AC Abadía-Molina, SB Berger, X Romero, MS O'Keeffe, DI Rojas-Barros, M Aleman, G Liao, E Maganto-García, M. Fresno, N. Wang, C. Detre et C. Terhorst, « Cutting edge: Slamf8 is a negative regulator of Nox2 activity in macrophages », Journal of immunology (Baltimore, Md. : 1950), vol. 188, n^o 12,‎ 2012, p. 5829–32 (PMID 22593622, PMCID 3370125, DOI 10.4049/jimmunol.1102620)

[5] (en) Sebastian Pott, Nima K. Kamrani, Guillaume Bourque, Sven Pettersson et Edison T. Liu, « PPARG Binding Landscapes in Macrophages Suggest a Genome-Wide Contribution of PU.1 to Divergent PPARG Binding in Human and Mouse », PLoS ONE, vol. 7, n^o 10,‎ 2012, e48102 (DOI 10.1371/journal.pone.0048102)

[1]

[2]

[3]

[4]

[5]